Researchers from SWOG Cancer Research Network, a clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), will present 30 abstracts at the 2023 annual meeting of the American Society of Clinical Oncology (ASCO), June 2 – 6 in Chicago. They have also contributed to an additional 11 abstracts on studies led by other groups.
Primary results from SWOG trials S1011, S1826, S1714, and S1929, along with results of an analysis from the S1609 DART trial, have been accepted for oral presentations (including a plenary presentation for S1826), and results to be presented in those sessions will be shared publicly during the meeting.
Here are highlights from some of the other SWOG work to be presented at ASCO 2023.
These studies have been supported by the NCI, part of the NIH, led by SWOG, and conducted by the NIH-funded NCI National Clinical Trials Network (NCTN) and/or NCI Community Oncology Research Program (NCORP). Various NCI pharmaceutical collaborators provided support for these studies.
S1216 was funded by the NIH/NCI through grants CA180888, CA180819, CA180820, and CA180821 and in part by Millennium Pharmaceuticals, Inc. (Takeda Pharmaceutical Company Ltd).
Study S1609 was funded by the NIH/NCI through grants U10CA180888, U10CA180819, U10CA180820, U10CA180868, and was supported in part by Bristol Myers Squibb Company through a Cooperative Research and Development Agreement between the company and the NCI.
SWOG Cancer Research Network is part of the National Cancer Institute's National Clinical Trials Network and the NCI Community Oncology Research Program and is part of the oldest and largest publicly funded cancer research network in the nation. SWOG has more than 18,000 members in 45 states and nine other countries who design and conduct clinical trials to improve the lives of people with cancer. SWOG trials have led to the approval of 14 cancer drugs, changed more than 100 standards of cancer care, and saved more than 3 million years of human life. Learn more at swog.org, and follow us on Twitter at @SWOG.
Randomized controlled/clinical trial
People